Print Preview Area

Status of combination drugs with betamethasone dipropionate and salicylic acid in the treatment of skin diseases
Advances in Dermatology and Allergology, 08/03/2012

Pastuszka M et al. – Betamethasone dipropionate is a potent topical glucocorticoid which demonstrates anti–inflammatory, anti–proliferative, immunosuppressive and vasoconstrictive properties. Salicylic acid, in turn, has a strong keratolytic and slightly antiseptic action. The use of both components in one formulation provides a significantly better glucocorticoid penetration through the skin, which is crucial for the treatment of hyperkeratotic lesions.

Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Stay current on the latest literature, research and clinical news
Get special communications and offers from MDLinx and our sponsors
Receive invitations to paid market research

View Samples and Register

Stay current - Media Tool

Newsletter

RSS

Facebook

Receive free subspecialty
"5-minute updates" via email

Send the E-mail Newsletter to a Colleague

♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦

♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦

♦ Follow Us on Facebook

Search the latest
Medical Student Jobs
@MDLinx Career Center
View the full listing of physician jobs

Enter your email address and your password will be sent to you.
Email:

E-mail:
Password:
	Remember me Forgot your password?

Status of combination drugs with betamethasone dipropionate and salicylic acid in the treatment of skin diseases Advances in Dermatology and Allergology, 08/03/2012

Status of combination drugs with betamethasone dipropionate and salicylic acid in the treatment of skin diseases
Advances in Dermatology and Allergology, 08/03/2012